Luke Murphy

We have already made good progress on setting up Great British Energy, our publicly owned energy company overwhelmingly backed by the British people at the election.

We have published legislation, now making its passage through this House, announced former Siemens chief executive Juergen Maier as the start up chair, signed its first deal with the Crown Estate, and announced the GBE Headquarters in Aberdeen, delivering on our commitment to base the company in Scotland, the beating heart of our energy industry.

NHS England is working to detect people at risk of kidney disease through the NHS Health Check Programme. The programme, which is available for everyone between the ages of 40 and 74 years old, who is not already on a chronic disease register, assesses people’s health and risk of developing certain health problems. Using this information, patients are supported to make behavioural changes and access treatment which helps to prevent and detect kidney disease earlier.

NHS England has established the Renal Services Transformation Programme (RSTP), which aims to reduce unwarranted variation in the quality and accessibility of renal care, to improve outcomes and services for those with kidney disease. NHS England, through the RSTP and regional renal networks, is implementing initiatives to provide better, integrated care, to reduce health inequalities, and to focus on prevention and timely intervention for kidney disease.

Working in collaboration with the NHS RightCare Programme and the renal community, the RSTP has developed a renal toolkit to provide integrated care boards, renal clinical networks, and providers with tools, case studies, and principles to support transformation of services at a local level. The toolkit outlines principles to support better management of patients identified with chronic kidney disease (CKD) throughout their patient journey. The RSTP is also working closely with NHS England’s regional renal clinical networks to review this toolkit, and to work with local partners to develop transformation programmes that will focus on early identification and management of kidney disease, and will seek to reduce the number of patients progressing through various stages of CKD, and reduce the number of patients requiring dialysis. By supporting prevention and early intervention, the need for late-stage treatments will be reduced.

Regional renal clinical networks prioritise the prevention and early diagnosis of CKD within their transformation ambitions. This includes considerations to develop a unified approach to testing populations at risk of developing CKD, and includes raising awareness of diagnostic tools like urine albumin creatinine tests, enabling CKD diagnosis at stages 1 and 2. NHS England aims to improve awareness and access to these important urine and blood tests across primary and secondary care.

The National Institute for Health and Care Excellence’s guidance, Chronic kidney disease: Assessment and management [NG203], updated in November 2021, sets out best practice for clinicians in the diagnosis and management of CKD. The guidance covers the care and treatment of patients at risk of CKD. It includes recommendations on the monitoring of patients at risk of CKD, and aims to prevent or delay the progression of the disease. The guidance is available at the following link:

https://www.nice.org.uk/guidance/ng203

NHS England is working to detect people at risk of kidney disease through the NHS Health Check Programme. The programme, which is available for everyone between the ages of 40 and 74 years old, who is not already on a chronic disease register, assesses people’s health and risk of developing certain health problems. Using this information, patients are supported to make behavioural changes and access treatment which helps to prevent and detect kidney disease earlier.

NHS England has established the Renal Services Transformation Programme (RSTP), which aims to reduce unwarranted variation in the quality and accessibility of renal care, to improve outcomes and services for those with kidney disease. NHS England, through the RSTP and regional renal networks, is implementing initiatives to provide better, integrated care, to reduce health inequalities, and to focus on prevention and timely intervention for kidney disease.

Working in collaboration with the NHS RightCare Programme and the renal community, the RSTP has developed a renal toolkit to provide integrated care boards, renal clinical networks, and providers with tools, case studies, and principles to support transformation of services at a local level. The toolkit outlines principles to support better management of patients identified with chronic kidney disease (CKD) throughout their patient journey. The RSTP is also working closely with NHS England’s regional renal clinical networks to review this toolkit, and to work with local partners to develop transformation programmes that will focus on early identification and management of kidney disease, and will seek to reduce the number of patients progressing through various stages of CKD, and reduce the number of patients requiring dialysis. By supporting prevention and early intervention, the need for late-stage treatments will be reduced.

Regional renal clinical networks prioritise the prevention and early diagnosis of CKD within their transformation ambitions. This includes considerations to develop a unified approach to testing populations at risk of developing CKD, and includes raising awareness of diagnostic tools like urine albumin creatinine tests, enabling CKD diagnosis at stages 1 and 2. NHS England aims to improve awareness and access to these important urine and blood tests across primary and secondary care.

The National Institute for Health and Care Excellence’s guidance, Chronic kidney disease: Assessment and management [NG203], updated in November 2021, sets out best practice for clinicians in the diagnosis and management of CKD. The guidance covers the care and treatment of patients at risk of CKD. It includes recommendations on the monitoring of patients at risk of CKD, and aims to prevent or delay the progression of the disease. The guidance is available at the following link:

https://www.nice.org.uk/guidance/ng203

The Department is currently considering next steps to improve access to attention deficit hyperactivity disorder (ADHD) assessments. It is the responsibility of integrated care boards to make appropriate provision to meet the health and care needs of their local population, including ADHD assessments, in line with relevant National Institute for Health and Care Excellence guidelines.

We are supporting a taskforce that NHS England is establishing to look at ADHD service provision and its impact on patient experience. The taskforce will bring together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD and to help provide a joined-up approach in response to concerns around rising demand.

Alongside the work of the taskforce, NHS England will continue to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape, and capture examples from local health systems which are trialling innovative ways of delivering ADHD services to ensure best practice is captured and shared across the system.

I refer the hon. Member to the answer I gave on 29 October 2024 to Question 10950.

The standard process confirming the total funding amount for major infrastructure projects involves the review and approval of a Full Business Case. All trusts in the programme have previously received indicative funding allocations to support planning, however these are commercially sensitive.

Up to the end of the 2023/24, the total amount received by the Hampshire Hospitals NHS Foundation Trust in funding for their new hospital schemes is £8.5 million.

The breakdown of how much the trust received for their new hospital scheme is published annually as part of the Department’s Annual Reports and Accounts, with Public Dividend Capital to individual trusts included in the Financial Assistance Report under section 40 of the National Health Service Act 2006. The 2022/23 report is available at the following link:

https://www.gov.uk/government/publications/dhsc-annual-report-and-accounts-2022-to-2023

The trust is currently developing their Outline Business Case for the Hampshire Hospitals scheme and is at Royal Institute of British Architects Stage 0.

The Government is committed to ensuring that those living in the rented and leasehold sectors are protected from abuse and poor service at the hands of unscrupulous property agents. The Government will set out its position on the regulation of letting, managing and estate agents in due course.